Novel Oral Agent May Dial Down Ulcerative Colitis Severity

(MedPage Today) -- ORLANDO -- For patients diagnosed with moderate to severe ulcerative colitis, the investigational agent icanbelimod had mixed results in reducing the severity of disease within 12 weeks when used as induction and maintenance...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news